Pacific Pharma UK Limited Filleted Accounts Cover
Pacific Pharma UK Limited
Company No. 10483368
Information for Filing with The Registrar
30 November 2022
Pacific Pharma UK Limited Balance Sheet Registrar
at
30 November 2022
Company No.
10483368
Notes
2022
2021
£
£
Fixed assets
Tangible assets
4
15,01515,069
15,01515,069
Current assets
Debtors
5
6,03711,036
Cash at bank and in hand
142,516204,148
148,553215,184
Creditors: Amount falling due within one year
6
(240,576)
(199,958)
Net current (liabilities)/assets
(92,023)
15,226
Total assets less current liabilities
(77,008)
30,295
Creditors: Amounts falling due after more than one year
7
(701,654)
(697,079)
Provisions for liabilities
Deferred taxation
(2,711)
(2,721)
Net liabilities
(781,373)
(669,505)
Capital and reserves
Called up share capital
11
Profit and loss account
9
(781,374)
(669,506)
Total equity
(781,373)
(669,505)
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 30 November 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 03 October 2023
And signed on its behalf by:
I. Omer
Director
03 October 2023
Pacific Pharma UK Limited Notes to the Accounts Registrar
for the year ended 30 November 2022
1
General information
Its registered number is: 10483368
Its registered office is:
Suite G1, Hartsbourne House
Delta Gain
Carpenders Park
Watford
WD19 5EF
The financial statements are presented in Pound Sterling (£) which is the functional and presentational currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland (March 2018) and the Companies Act 2006.
2
Accounting policies
Turnover
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts and rebates. The following criteria must also be met before revenue is recognised:

Revenue from sale of services is recognised when the following conditions are satisfied:
- the amount of revenue can be measured reliably;
- the costs incurred or to be incurred in respect of the transaction can be measured reliably.
Tangible fixed assets and depreciation
Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
Plant and machinery
25% Reducing balance
Furniture, fittings and equipment
25% Reducing balance
Research and development costs
Expenditure on research and development is written off in the year it is incurred unless it meets the criteria to allow it to be capitalised. Costs of research are always written off in the year in which they are incurred. Where development costs are recognised as an asset, they are amortised over the period expected to benefit from them. Amortisation of the capitalised costs begins once the developed product comes into use, typically at rate of 33.33% straight line.
Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
Foreign currencies
The functional and presentational currency of the company is Sterling. The accounts are rounded to the nearest pound.
Transactions in currencies, other than the functional currency of the Company, are recorded at the rate of exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. all differences are taken to the profit and loss account. Non-monetary items that are measured at historic cost in a foreign currency are not retranslated.
Defined contribution pensions
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations.
The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.
Provisions
Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.

Provisions are charged as an expense to the profit and loss account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.

When payments are eventually made, they are charged to the provision carried in the balance sheet.
3
Employees
2022
2021
Number
Number
The average monthly number of employees (including directors) during the year was:
23
4
Tangible fixed assets
Plant and machinery
Fixtures, fittings and equipment
Total
£
£
£
Cost or revaluation
At 1 December 2021
18,3966,25224,648
Additions
-4,2244,224
At 30 November 2022
18,39610,47628,872
Depreciation
At 1 December 2021
4,1165,4639,579
Charge for the year
3,3968824,278
At 30 November 2022
7,5126,34513,857
Net book values
At 30 November 2022
10,8844,13115,015
At 30 November 2021
14,280
789
15,069
5
Debtors
2022
2021
£
£
VAT recoverable
4,9776,920
Other debtors
1,0604,116
6,03711,036
6
Creditors:
amounts falling due within one year
2022
2021
£
£
Trade creditors
44,539-
Taxes and social security
(3,839)
-
Other creditors
199,876199,958
240,576199,958
7
Creditors:
amounts falling due after more than one year
2022
2021
£
£
Bank loans and overdrafts
40,00050,000
Other creditors
661,654647,079
701,654697,079
8
Share Capital
Fully paid one share of £1.00
9
Reserves
Profit and loss account - includes all current and prior period retained profits and losses.
Pacific Pharma UK Limited1048336830 November 202201 December 2021false03 October 2023BTCSoftware AP Solution 2023 10.3.0110.3.01true104833682021-12-012022-11-30104833682022-11-30104833682021-11-3010483368core:WithinOneYear2022-11-3010483368core:WithinOneYear2021-11-3010483368core:AfterOneYear2022-11-3010483368core:AfterOneYear2021-11-3010483368core:ShareCapital2022-11-3010483368core:ShareCapital2021-11-3010483368core:RetainedEarningsAccumulatedLosses2022-11-3010483368core:RetainedEarningsAccumulatedLosses2021-11-3010483368bus:RegisteredOffice2021-12-012022-11-3010483368core:PlantMachinery2021-12-012022-11-3010483368core:FurnitureFittingsToolsEquipment2021-12-012022-11-30104833682020-12-012021-11-3010483368core:PlantMachinery2021-12-0110483368core:FurnitureFittingsToolsEquipment2021-12-01104833682021-12-0110483368core:PlantMachinery2022-11-3010483368core:FurnitureFittingsToolsEquipment2022-11-3010483368core:RetainedEarningsAccumulatedLosses2021-12-012022-11-3010483368bus:SmallEntities2021-12-012022-11-3010483368bus:FullAccounts2021-12-012022-11-3010483368bus:AuditExempt-NoAccountantsReport2021-12-012022-11-3010483368bus:Director12021-12-012022-11-3010483368bus:PrivateLimitedCompanyLtd2021-12-012022-11-30iso4217:GBPxbrli:pure